New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...